For the quarter ending 2026-03-31, AIRS had $8,241K increase in cash & cash equivalents over the period. $5,220K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on impairment of long-lived assets | - | - | -7,137 | -108 |
| Net loss | -2,397 | 1,283 | -9,512 | -3,438 |
| Depreciation and amortization | 3,021 | 3,076 | 3,217 | 6,488 |
| Equity-based compensation | 559 | -1,385 | 1,125 | 2,591 |
| Non-cash interest expense amortization of debt costs | 136 | 147 | 136 | 242 |
| Deferred income taxes | - | -5,914 | - | - |
| Loss on impairment of long-lived assets | - | 4,575 | - | - |
| Cost related to closing location | - | -2,152 | - | - |
| Taxes receivable | 475 | -1,958 | 1,653 | -1,251 |
| Prepaid expense and other current assets | 158 | 2,267 | 1,582 | 591 |
| Other assets | -1,188 | 981 | -2,732 | -4,918 |
| Accounts payable | 2,112 | 919 | 1,121 | -1,461 |
| Deferred revenue and patient deposits | 2,029 | 1,024 | -241 | -48 |
| Accrued and other liabilities | -744 | 127 | -2,705 | -4,208 |
| Net cash provided by operating activities | 5,271 | -2,531 | -225 | 5,852 |
| Purchases of property and equipment, net | 51 | 58 | 180 | 2,166 |
| Distribution to member | - | 0 | - | - |
| Net cash used in investing activities | -51 | -58 | -180 | -2,166 |
| Dividends paid to shareholders | - | 0 | 0 | 0 |
| Payments on term loan | 11,365 | 910 | 910 | 11,973 |
| Payments for debt modification | 0 | 105 | 51 | 237 |
| Payments on revolving credit facility | - | -10,000 | 5,000 | - |
| Proceeds from public offerings, net | 14,591 | 4,996 | -240 | 14,008 |
| Payments on revolving credit facility | - | - | - | 5,000 |
| Payment of taxes withheld through vested equity-based compensation | 195 | 0 | 0 | 56 |
| Other financing activity | -10 | 1,652 | -1,178 | -474 |
| Net cash provided by/(used in) financing activities | 3,021 | 5,633 | -2,379 | -3,732 |
| Effect of exchange rate changes on cash and cash equivalents | - | - | - | 0 |
| Net increase/(decrease) in cash and cash equivalents | 8,241 | 3,044 | -2,784 | -46 |
| Beginning of period | 8,449 | 2,830 | 8,235 | - |
| End of period | 16,690 | 3,044 | 5,405 | - |
Airsculpt Technologies, Inc. (AIRS)
Airsculpt Technologies, Inc. (AIRS)